前列腺是臨床上重要的男性性器官，其主要功能是製造精液。在全球範圍內，它是男性第二常見的癌症，也是男性第五大癌症死亡原因。儘管對前列腺癌的了解有所改善，但目前使用血清前列腺特異性抗原（PSA）作為診斷標記仍不理想。
適應症：Prostate Cancer
收案條件
納入條件
- Adult male patients with age \> 18 years old
- Subject has elevated serum PSA level above 4ng/ml
- Clinical planned for prostatic biopsy.
排除條件
- Patient with recent urinary tract infection within 6 weeks prior to PSA testing and urine collection.
- Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to PSA testing and urine collection.
- Patient with consumption of 5 alpha reductase inhibitors in past 6 months.
- Patient did not receive any surgery for prostatic pathology
- Patient refused or unable to provide consent for the study
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。